Evaluation of the impact of abdominal obesity on glucose and lipid metabolism disorders in adults with Down syndrome

Research in Developmental Disabilities

Volumn 35, Issue 11, 2014, Pages 2942-2949

  Real de Asua, Diego ^a   Parra, Pedro ^a   Costa, Ramón ^a   Moldenhauer, Fernando ^a   Suarez, Carmen ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Abdominal obesity; Anthropometry; Body fat distribution; Body mass index; Down syndrome

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; THYROTROPIN; GLUCOSE BLOOD LEVEL;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; DISORDERS OF LIPID METABOLISM; DOWN SYNDROME; DRUG USE; DYSLIPIDEMIA; EPIDEMIOLOGICAL DATA; FAT INTAKE; FEMALE; FREE THYROXINE INDEX; HUMAN; INCIDENCE; INSULIN RESISTANCE; LIPID ANALYSIS; MALE; METABOLIC SYNDROME X; OUTPATIENT; PREVALENCE; SEX RATIO; SPAIN; SUBCLINICAL HYPOTHYROIDISM; TERTIARY CARE CENTER; WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO; DYSLIPIDEMIAS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; OBESITY, ABDOMINAL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DOWN SYNDROME; DYSLIPIDEMIAS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; WAIST CIRCUMFERENCE; WAIST-HEIGHT RATIO;

EID: 84940256683     PISSN: 08914222     EISSN: 18733379     Source Type: Journal    
DOI: 10.1016/j.ridd.2014.07.038     Document Type: Article

References (43)

1. Adelekan T., Magge S., Shults J., Stallings V., Stettler N. Lipid profiles of children with Down syndrome compared with their siblings. Pediatrics 2012, 129:e1382-e1387.
2. Agiovlasitis S., Collier S.R., Baynard T., Echols G.H., Goulopoulou S., Figueroa A., et al. Autonomic response to upright tilt in people with and without Down syndrome. Research in Developmental Disabilities 2010, 31:857-863.
3. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart. Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
4. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35:S64-S71.
5. Ascaso J.F., Pardo S., Real J.T., Lorente R.I., Priego A., Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003, 26:3320-3325.
6. Ascaso J.F., Romero P., Real J.T., Priego A., Valdecabres C., Carmena R. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Medicina Clínica (Barcelona) 2001, 117:530-533.
7. Ashwell M., Gunn P., Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: Systematic review and meta-analysis. Obesity Reviews 2012, 13:275-286.
8. Asia Pacific Cohort Studies Collaboration Joint effect of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region. Circulation 2005, 112:3384-3390.
9. Bergholdt R., Eising S., Nerup J., Pociot F. Increased prevalence of Down's syndrome in individuals with type 1 diabetes in Denmark: A nationwide population-based study. Diabetologia 2006, 49:1179-1182.
10. Block G., Gillespie C., Rosenbaum E.H., Jenson C. A rapid food screener to assess fat and fruit and vegetable intake. American Journal of Preventive Medicine 2000, 18:284-288.
11. Browning L.M., Hsieh S.D., Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutrition Research Reviews 2010, 23:247-269.
12. Bullo M., Garcia-Aloy M., Martinez-Gonzalez M.A., Corella D., Fernandez-Ballart J.D., Fiol M., et al. Association between a healthy lifestyle and general obesity and abdominal obesity in an elderly population at high cardiovascular risk. Preventive Medicine 2011, 53:155-161. for the PREDIMED study investigators.
13. Corsi M.M., Dogliotti G., Pedroni F., Galliera E., Malavazos A.E., Villa R., et al. Adipocytokines in Down's syndrome, an atheroma-free model: Role of adiponectin. Archives of Gerontology and Geriatrics 2009, 48:106-109.
14. de Winter C.F., Bastiaanse L.P., Hilgenkamp T.I.M., Evenhuis H.M., Echteld M.A. Overweight and obesity in older people with intellectual disability. Research in Developmental Disabilities 2012, 33:1722-1731.
15. de Winter C.F., Magilsen K.W., Van Alfen J.C., Willemsen S.P., Evenhuis H.M. Metabolic syndrome in 25% of older people with intellectual disability. Family Practice 2011, 28:141-144.
16. Dehghan M., Merchant A.T. Is bioelectrical impedance accurate for use in large epidemiological studies?. Nutrition Journal 2008, 7:26.
17. Deurenberg P., Andreoli A., Borg P., Kukkonen-Harjula K., de Lorenzo A., van Marken Lichtenbelt W.D., et al. The validity of predicted body fat percentage from body mass index and from impedance in samples of five European populations. European Journal of Clinical Nutrition 2001, 55:973-979.
18. Draheim C.C., Geijer J.R., Dengel D.R. Comparison of intima-media thickness of the carotid artery and cardiovascular disease risk factors in adults with versus without the Down syndrome. American Journal of Cardiology 2010, 106:1512-1516.
19. Draheim C.C., McCubbin J.A., Williams D.P. Differences in cardiovascular disease risk between nondiabetic adults with mental retardation with and without Down syndrome. American Journal of Mental Retardation 2002, 107:201-211.
20. Ervin R.B. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. National Health Statistics Reports 2009, 1-7.
21. Fujiura G.T., Fitzsimons N., Marks B. Predictors of BMI among adults with Down syndrome: The social context of health promotion. Research in Developmental Disabilities 1997, 18:261-274.
22. Giacchetti G., Sechi L.A., Rilli S., Carey R.M. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends in Endocrinology and Metabolism 2005, 16:120-126.
23. Going S.B., Lohman T.G., Cussler E.C., Williams D.P., Morrison J.A., Horn P.S. Percent body fat and chronic disease risk factors in U.S. children and youth. American Journal of Preventive Medicine 2011, 41:S77-S86.
24. Goulopoulou S., Baynard T., Collier S., Giannopoulou I., Figueroa A., Beets M., et al. Cardiac autonomic control in individuals with Down syndrome. American Journal of Mental Retardation 2006, 111:27-34.
25. Irving C., Basu A., Richmond S., Burn J., Wren C. Twenty-year trends in prevalence and survival of Down syndrome. European Journal of Human Genetics 2008, 16:1336-1340.
26. Kerins G., Petrovic K., Bruder M.B., Gruman C. Medical conditions and medication use in adults with Down syndrome: A descriptive analysis. Downs Syndrome Research and Practice 2008, 12:141-147.
27. Laurson K.R., Eisenmann J.C., Welk G.J. Development of youth percent body fat standards using receiver operating characteristic curves. American Journal of Preventive Medicine 2011, 41:S93-S99.
28. Licastro F., Dogliotti G., Goi G., Malavazos A.E., Chiappelli M., Corsi M.M. Oxidated low-density lipoproteins (oxLDL) and peroxides in plasma of Down syndrome patients. Archives of Gerontology and Geriatrics 2007, 44:225-232.
29. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
30. Melville C.A., Cooper S.A., McGrother C.W., Thorp C.F., Collacott R. Obesity in adults with Down syndrome: A case-control study. Journal of Intellectual Disability Research 2005, 49:125-133.
31. Moreno-Palanco M.A., Ibanez-Sanz P., Ciria-de Pablo C., Pizarro-Portillo A., Rodriguez-Salvanes F., Suarez-Fernandez C. Impact of comprehensive and intensive treatment of risk factors concerning cardiovascular mortality in secondary prevention: MIRVAS Study. Revista Española de Cardiología 2011, 64:179-185.
32. Multiple Risk Factor Intervention Trial Research Group Relationship between baseline risk factors, coronary heart disease, and total mortality in the multiple risk factor intervention trial. Preventive Medicine 1986, 15:254-273.
33. Murdoch J.C., Rodger J.C., Rao S.S., Fletcher C.D., Dunnigan M.G. Down's syndrome: An atheroma-free model?. British Medical Journal 1977, 2:226-228.
34. NCEP Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, education, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of the American Medical Association 2001, 285:2486-2497.
35. Okamoto Y., Kihara S., Funahashi T., Matsuzawa Y., Libby P. Adiponectin: A key adipocytokine in metabolic syndrome. Clinical Science (London) 2006, 110:267-278.
36. Prasher V.P. Overweight and obesity amongst Down's syndrome adults. Journal of Intellectual Disability Research 1995, 39:437-441.
37. Reaven G.M. Insulin resistance: The link between obesity and cardiovascular disease. Medical Clinics of North America 2011, 95:875-892.
38. Rodrigues A.N., Coelho L.C., Goncalves W.L., Gouvea S.A., Vasconcellos M.J., Cunha R.S., et al. Stiffness of the large arteries in individuals with and without Down syndrome. Vascular Health and Risk Management 2011, 7:375-381.
39. Rubin S.S., Rimmer J.H., Chicoine B., Braddock D., McGuire D.E. Overweight prevalence in persons with Down syndrome. Mental Retardation 1998, 36:175-181.
40. Tsigos C., Hainer V., Basdevant A., Finer N., Fried M., Mathus-Vliegen E., et al. Management of obesity in adults. European Clinical Practice Guidelines. Obesity Facts 2008, 1:106-116. for the Obesity Management Task Force of the European Association for the Study of Obesity.
41. WHO Global health risks. Mortality and burden of disease attributable to selected major risks 2009, World Health Organization, Geneva, Switzerland.
42. Yang Q., Rasmussen S.A., Friedman J.M. Mortality associated with Down's syndrome in the USA from 1983 to 1997: A population-based study. Lancet 2002, 359:1019-1025.
43. Yla-Herttuala S., Luoma J., Nikkari T., Kivimaki T. Down's syndrome and atherosclerosis. Atherosclerosis 1989, 76:269-272.